Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo O Perez

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Diseases of the Colon and Rectum|March 9, 2016
Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant ChemoradiationAngelita Habr-Gama, Patricio B Lynn, J Márcio N Jorge, et al.
International Journal of Colorectal Disease|August 6, 2015
Management of adenomas within the area of rectal cancer that develop complete pathological responseAngelita Habr-Gama, Maria Regina Vianna, Guilherme P São Julião, et al.
Diseases of the Colon and Rectum|June 13, 2019
Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!Angelita Habr-Gama, Guilherme P São Julião, Laura M Fernandez, et al.
Genomics|February 11, 2015
ICRmax: an optimized approach to detect tumor-specific interchromosomal rearrangements for clinical applicationElisa R Donnard, Paola A Carpinetti, Fábio C P Navarro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2025
Reply to: "Risks of Organ Preservation in Rectal Cancer: Beyond Distant Metastases, Ultimate Local Failure Can Also Be a Problem," "Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear," and "Distant Metastases With Nonoperative Management in Rectal Cancer: Challenges in Defining Risk"Laura M Fernandez, Guilherme P São Julião, Carlos Cerdan-Santacruz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2026
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal CancersBarbara Noiret, Rodrigo O Perez, Thierry Conroy, et al.
Diseases of the Colon and Rectum|August 10, 2016
Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal CancerDalton A Dos Anjos, Rodrigo O Perez, Angelita Habr-Gama, et al.
Plos One|July 14, 2017
E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancerCamila M Lopes-Ramos, Bruna P Barros, Fernanda C Koyama, et al.
Diseases of the Colon and Rectum|December 17, 2019
Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the WinnersLeandro Jimenez, Rodrigo O Perez, Guilherme Pagin São Julião, et al.
Lancet (London, England)|October 1, 2013
Strategies to improve clinical research in surgery through international collaborationKjetil Søreide, Derek Alderson, Anders Bergenfelz, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Diseases of the Colon and Rectum|March 9, 2016
Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant ChemoradiationAngelita Habr-Gama, Patricio B Lynn, J Márcio N Jorge, et al.
International Journal of Colorectal Disease|August 6, 2015
Management of adenomas within the area of rectal cancer that develop complete pathological responseAngelita Habr-Gama, Maria Regina Vianna, Guilherme P São Julião, et al.
Diseases of the Colon and Rectum|June 13, 2019
Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!Angelita Habr-Gama, Guilherme P São Julião, Laura M Fernandez, et al.
Genomics|February 11, 2015
ICRmax: an optimized approach to detect tumor-specific interchromosomal rearrangements for clinical applicationElisa R Donnard, Paola A Carpinetti, Fábio C P Navarro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2025
Reply to: "Risks of Organ Preservation in Rectal Cancer: Beyond Distant Metastases, Ultimate Local Failure Can Also Be a Problem," "Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear," and "Distant Metastases With Nonoperative Management in Rectal Cancer: Challenges in Defining Risk"Laura M Fernandez, Guilherme P São Julião, Carlos Cerdan-Santacruz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2026
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal CancersBarbara Noiret, Rodrigo O Perez, Thierry Conroy, et al.
Diseases of the Colon and Rectum|August 10, 2016
Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal CancerDalton A Dos Anjos, Rodrigo O Perez, Angelita Habr-Gama, et al.
Plos One|July 14, 2017
E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancerCamila M Lopes-Ramos, Bruna P Barros, Fernanda C Koyama, et al.
Diseases of the Colon and Rectum|December 17, 2019
Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the WinnersLeandro Jimenez, Rodrigo O Perez, Guilherme Pagin São Julião, et al.
Lancet (London, England)|October 1, 2013
Strategies to improve clinical research in surgery through international collaborationKjetil Søreide, Derek Alderson, Anders Bergenfelz, et al.
Pageof 8